Systems and methods for superdisintegrant-based composite particles for dispersion and dissolution of agents
The present disclosure provides improved systems and methods utilizing colloidal/ultrafine superdisintegrant-based composite particles for dispersion and/or dissolution of active pharmaceutical agents. In general, the present disclosure utilizes a surfactant-free or near surfactant-free formulation by incorporating a wet milled SDI as a dispersant in the formulation. As such, the present disclosure provides for the preparation of surfactant-free or substantially surfactant-free formulations (e.g., nano-composite micro-particle formulations) by incorporating a wet-milled superdisintegrant (SDI) as the dispersant in the formulations. The advantageous SDI particles (e.g., colloidal/ultrafine SDI particles) of the present disclosure can be used to break-up the aggregates (e.g., nanoparticle aggregates) of the active agents (e.g. poorly water-soluble drugs) in the formulations (e.g., micro-particle formulations) and enhance the recovery of the nanoparticles of active agents during aqueous re-dispersion and their dissolution rate in vitro and in vivo.
1. A method for fabricating a formulation comprising:
providing active agent particles in an aqueous suspension;
introducing the aqueous suspension of active agent particles to a wet media mill having a milling chamber;
pumping the aqueous suspension of active agent particles through the wet media mill;
operating the wet media mill at a pre-determined rpm setting;
periodically and gradually introducing superdisintegrant (SDI) particles to the aqueous suspension of active agent particles in the operating wet media mill to form an aqueous suspension of SDI particles and active agent particles in the operating wet media mill;
co-wet-milling the aqueous suspension of SDI particles and the active agent particles in the operating wet media mill to form a co-wet-milled suspension of co-wet-milled SDI particles and active agent particles, the co-wet-milled suspension including colloidal and ultrafine SDI particles and colloidal particles and nanoparticles of active agents;
drying the co-wet-milled suspension of SDI particles and active agent particles to form a composite of SDI particles and active agent particles;
wherein the co-wet-milled SDI particles have a particle size of less than about 5 microns;
wherein the SDI particles and active agent particles are co-wet-milled in the wet media mill with milling media.
2. The method of claim 1 further comprising the step of incorporating the composite of SDI particles and active agent particles into a solid dosage form.
3. The method of claim 1 , wherein at least a portion of the composite of SDI particles and active agent particles is coated on an excipient.
4. The method of claim 1 , wherein the drying step includes a drying technique selected from the group consisting of fluidized bed drying, spray drying, vacuum drying, freeze drying, spray freeze drying, oven drying, fluidized bed coating and fluidized bed granulation.
5. The method of claim 1 , wherein the co-wet-milled suspension further includes a stabilizer.
6. The method of claim 5 , wherein the stabilizer is selected from the group consisting of soluble polymers, hydroxpropylmethyl cellulose, hydroxpropyl cellulose and polyvinylpyrrolidone and combinations thereof.
7. The method of claim 1 wherein the composite is a nano-composite of SDI and active agent micro-particles.
8. The method of claim 1 , wherein the active agent particles include particles selected from the group consisting of pharmaceutical active agents, poorly water soluble drugs, diagnostic agents, peptides, proteins, biologic agents and combinations thereof.
9. The method of claim 1 ,
wherein the milling media has a particle size of about 25 μm to about 4 mm.
10. The method of claim 1 , wherein the temperature inside the milling chamber is maintained at a pre-determined temperature via a chiller during the co-wet-milling of the aqueous suspension of SDI particles and the active agent particles in the operating wet media mill.
11. The method of claim 1 , wherein the SDI particles include particles selected from the group consisting of croscarmellose sodium particles, sodium starch glycolate particles, crosslinked polyvinyl pyrrolidone particles, anionic SDI particles and neutral SDI particles.
12. The method of claim 1 , wherein the drying step includes coating and drying the co-wet-milled suspension onto an excipient via a fluidized bed processor to form a nano-composite of SDI and active agent particles on at least a portion of the excipient.
13. The method of claim 1 , wherein prior to co-wet-milling the SDI particles and active agent particles, the SDI particles are provided in the suspension at a weight/weight (w/w) % of from about 0.50 w/w % to about 5.0 w/w % with respect to the weight of the water or suspension; and
wherein the active agent particles are provided in the suspension at a weight/weight (w/w) % of from about 5.0 w/w % to about 40.0 w/w % with respect to the weight of the water or suspension.
14. The method of claim 1 , wherein the drying step includes drying the co-wet-milled suspension via a spray dryer to form a nano-composite of SDI and active agent particles.
15. A method for fabricating a formulation comprising:
providing active agent particles in an aqueous suspension;
introducing the aqueous suspension of active agent particles to a wet media mill having a milling chamber;
pumping the aqueous suspension of active agent particles through the wet media mill;
operating the wet media mill at a pre-determined rpm setting;
periodically and gradually introducing superdisintegrant (SDI) particles to the aqueous suspension of active agent particles in the operating wet media mill to form an aqueous suspension of SDI particles and active agent particles in the operating wet media mill;
co-wet-milling the aqueous suspension of SDI particles and the active agent particles in the operating wet media mill to form a co-wet-milled nano-particle suspension of co-wet-milled SDI particles and active agent particles;
drying the co-wet-milled nano-particle suspension to form a nano-composite of SDI and active agent micro-particles;
incorporating the dried nano-composite into a solid dosage form;
wherein the co-wet-milled SDI particles have a particle size of less than about 5 microns;
wherein the SDI particles and active agent particles are co-wet-milled in the wet media mill with milling media;
wherein the milling media has a particle size of about 25 μm to about 4 mm; and
wherein the temperature inside the milling chamber is maintained at a pre-determined temperature via a chiller during the co-wet-milling of the aqueous suspension of SDI particles and the active agent particles in the operating wet media mill.